Review ArticleArticles

Androgen Receptor and PIM1 Expression in Tumor Tissue of Patients With Triple-negative Breast Cancer

ALIKI NTZIFA, ARETI STRATI, GEORGIA-ANGELIKI KOLIOU, FLORA ZAGOURI, DIMITRIOS PECTASIDES, GEORGE PENTHEROUDAKIS, CHRISTOS CHRISTODOULOU, HELEN GOGAS, CHRISTINA MAGKOU, CONSTANTINA PETRAKI, PARIS KOSMIDIS, GERASIMOS ARAVANTINOS, VASSILIKI KOTOULA, GEORGE FOUNTZILAS and EVI LIANIDOU
Cancer Genomics & Proteomics March 2021, 18 (2) 147-156; DOI: https://doi.org/10.21873/cgp.20249

Article Information

vol. 18 no. 2 147-156
DOI 
https://doi.org/10.21873/cgp.20249
PubMed 
33608311
Published By 
International Institute of Anticancer Research
Print ISSN 
1109-6535
Online ISSN 
1790-6245
History 
  • Received December 7, 2020
  • Revision received January 11, 2021
  • Accepted January 13, 2021
  • Published online February 19, 2021.
Copyright & Usage 
Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. ALIKI NTZIFA1,
  2. ARETI STRATI1,
  3. GEORGIA-ANGELIKI KOLIOU2,
  4. FLORA ZAGOURI3,
  5. DIMITRIOS PECTASIDES4,
  6. GEORGE PENTHEROUDAKIS5,6,
  7. CHRISTOS CHRISTODOULOU7,
  8. HELEN GOGAS8,
  9. CHRISTINA MAGKOU9,
  10. CONSTANTINA PETRAKI10,
  11. PARIS KOSMIDIS11,
  12. GERASIMOS ARAVANTINOS12,
  13. VASSILIKI KOTOULA13,14,
  14. GEORGE FOUNTZILAS14,15,16 and
  15. EVI LIANIDOU1⇑
  1. 1Analysis of Circulating Tumor Cells Laboratory, Laboratory of Analytical Chemistry, Department of Chemistry, University of Athens, Athens, Greece;
  2. 2Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece;
  3. 3Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece;
  4. 4Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, Athens, Greece;
  5. 5Department of Medical Oncology, Medical School, University of Ioannina, Ioannina, Greece;
  6. 6Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece;
  7. 7Second Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece;
  8. 8First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece;
  9. 9Pathology Department, Evangelismos Hospital, Athens, Greece;
  10. 10Department of Pathology, Metropolitan Hospital, Piraeus, Greece;
  11. 11Second Department of Medical Oncology, Hygeia Hospital, Athens, Greece;
  12. 12Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece;
  13. 13Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece;
  14. 14Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece;
  15. 15Aristotle University of Thessaloniki, Thessaloniki, Greece;
  16. 16German Oncology Center, Limassol, Cyprus
  1. Correspondence to: Evi Lianidou, Ph.D., Professor of Analytical Chemistry – Clinical Chemistry, Laboratory of Analytical Chemistry, Analysis of Circulating Tumor Cells (ACTC) Laboratory, Department of Chemistry, University of Athens, Athens, Greece. E-mail: lianidou{at}chem.uoa.gr
View Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Androgen Receptor and PIM1 Expression in Tumor Tissue of Patients With Triple-negative Breast Cancer
ALIKI NTZIFA, ARETI STRATI, GEORGIA-ANGELIKI KOLIOU, FLORA ZAGOURI, DIMITRIOS PECTASIDES, GEORGE PENTHEROUDAKIS, CHRISTOS CHRISTODOULOU, HELEN GOGAS, CHRISTINA MAGKOU, CONSTANTINA PETRAKI, PARIS KOSMIDIS, GERASIMOS ARAVANTINOS, VASSILIKI KOTOULA, GEORGE FOUNTZILAS, EVI LIANIDOU
Cancer Genomics & Proteomics Mar 2021, 18 (2) 147-156; DOI: 10.21873/cgp.20249
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Keywords